Deprescribing psychotropic medications in children: results of a national qualitative study

被引:16
作者
Barnett, Erin R. [1 ,2 ,3 ,4 ]
Trepman, Alissa Z. [3 ]
Fuson, Hannah A. [3 ,5 ]
Acquilano, Stephanie C. [3 ]
McLaren, Jennifer L. [1 ,2 ,3 ]
Woloshin, Steven [3 ,6 ]
Leyenaar, Joanna K. [2 ,3 ,7 ]
机构
[1] Geisel Sch Med Dartmouth, Dept Psychiat, Lebanon, NH USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[3] Geisel Sch Med Dartmouth, Vulnerable Children Res Grp, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA
[4] Geisel Sch Med Dartmouth, Dartmouth Trauma Intervent Res Ctr, Lebanon, NH USA
[5] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA
[6] Geisel Sch Med Dartmouth, Ctr Med & Media, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA
[7] Geisel Sch Med Dartmouth, Dept Pediat, Lebanon, NH USA
关键词
evidence-based medicine; mental health; paediatrics; qualitative research; health policy; YOUTH; POLYPHARMACY; RISPERIDONE; DISCONTINUATION; ADOLESCENTS; GUIDELINES; REDUCTION; MEDICAID; OUTCOMES; CARE;
D O I
10.1136/bmjqs-2019-010033
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background and Objective Prescriptions for psychotropic medications to children have risen dramatically in recent years despite few regulatory approvals and growing concerns about side effects. Government policy and numerous programmes are attempting to curb this problem. However, the perspectives of practising clinicians have not been explored. To characterise the perspectives and experiences of paediatric primary care clinicians and mental health specialists regarding overprescribing and deprescribing psychotropic medications in children. Methods We conducted 24 semistructured interviews with clinicians representing diverse geographic regions and practice settings in the USA. Interview questions focused on clinician perspectives surrounding overprescribing and experiences with deprescribing. We transcribed audio files verbatim and verified them for accuracy. We analysed transcripts using a grounded theory approach, identifying emergent themes and developing a conceptual model using axial coding. Results Analysis yielded themes within four domains: social and clinical contextual factors contributing to overprescribing, opportunities for deprescribing, and facilitators and barriers to deprescribing in paediatric outpatient settings. Most participants recognised the problem of overprescribing, and they described complex clinical and social contextual factors, as well as internal and external pressures, that contribute to overprescribing. Opportunities for deprescribing included identification of high-risk medications, routine reassessment of medication needs and recognition of the broader social needs of vulnerable children. Facilitators and barriers to deprescribing were both internal (eg, providing psychoeducation to families) and external (eg, parent and child preferences) to clinicians. Conclusion Our findings highlight a discrepancy between clinicians' concerns about overprescribing and a lack of resources to support deprescribing in outpatient paediatric settings. To successfully initiate deprescribing, clinicians will need practical tools and organisational supports, as well as social resources for vulnerable families.
引用
收藏
页码:655 / 663
页数:9
相关论文
共 44 条
[1]   Challenges and Enablers of Deprescribing: A General Practitioner Perspective [J].
Ailabouni, Nagham J. ;
Nishtala, Prasad S. ;
Mangin, Dee ;
Tordoff, June M. .
PLOS ONE, 2016, 11 (04)
[2]  
American Academy of Child and Adolescent Psychiatrists, 2005, AACAP POS STAT OV PS
[3]   Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis [J].
Anderson, Kristen ;
Stowasser, Danielle ;
Freeman, Christopher ;
Scott, Ian .
BMJ OPEN, 2014, 4 (12)
[4]  
[Anonymous], 2019, J CLIN PSYCHIAT
[5]  
[Anonymous], 2019, J HIGH ENERGY PHYS, DOI DOI 10.1007/JHEP05(2019)137
[6]   DEPRESCRIBING IN CHILD AND ADOLESCENT PSYCHIATRY: WHERE, WHEN, AND HOW TO SAFELY REDUCE POLYPHARMACY IN CLINICAL SETTINGS [J].
Bellonci, Christopher ;
Carlson, Gabrielle A. .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10) :S37-S37
[7]   Concurrent reductions in psychotropic medication, assault, and physical restraint in two residential treatment programs for youth [J].
Bellonci, Christopher ;
Huefner, Jonathan C. ;
Griffith, Annette K. ;
Vogel-Rosen, Georgi ;
Smith, Gail L. ;
Preston, Scott .
CHILDREN AND YOUTH SERVICES REVIEW, 2013, 35 (10) :1773-1779
[8]   Use of Psychotropic Medications Among Youth in Treatment Foster Care [J].
Brenner, Sharon L. ;
Southerland, Dannia G. ;
Burns, Barbara J. ;
Wagner, H. Ryan ;
Farmer, Elizabeth M. Z. .
JOURNAL OF CHILD AND FAMILY STUDIES, 2014, 23 (04) :666-674
[9]   Cardiometabolic Outcomes in Children and Adolescents Following Discontinuation of Long-Term Risperidone Treatment [J].
Calarge, Chadi A. ;
Nicol, Ginger ;
Schlechte, Janet A. ;
Burns, Trudy L. .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (03) :120-129
[10]  
Center for Health Care Strategies, 2018, IMPR US PSYCH MED CH